Skip to main content
V

VoxNeuro

VoxNeuro develops software that utilizes advanced neuroimaging and machine learning algorithms to assess brain health and cognitive function. The platform provides objective insights into neurological conditions, enabling early detection and personalized treatment plans for patients.

Hamilton, CanadaFounded 201792K+ followers
Updated 20 months ago

Funding

$9.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

GT
Funding rounds are not available yet.

Founders

Product

Problem

Assessing brain health and cognitive function currently relies on subjective evaluations and traditional neuroimaging techniques, which may lack the sensitivity to detect subtle neurological changes or provide objective insights into cognitive processes. This can lead to delayed or inaccurate diagnoses and limit the ability to personalize treatment plans for patients with neurological conditions.

Solution

VoxNeuro develops software that employs advanced neuroimaging and machine learning algorithms to provide objective assessments of brain health and cognitive function. The platform analyzes brainwave data to identify biomarkers associated with various neurological conditions, offering clinicians quantitative insights into cognitive performance. By leveraging machine learning, VoxNeuro aims to improve the accuracy and efficiency of neurological evaluations, enabling earlier detection of cognitive impairments and more personalized treatment strategies. The software provides clinicians with objective data to support their clinical decision-making, potentially leading to improved patient outcomes.

Target Audience

The primary target audience includes neurologists, psychiatrists, and other healthcare professionals involved in the diagnosis and treatment of neurological and cognitive disorders.

Features

  • Advanced neuroimaging analysis using proprietary algorithms
  • Machine learning-based identification of neurological biomarkers
  • Quantitative assessment of cognitive function
  • Objective data to support clinical decision-making
This profile is AI-generated and may contain inaccuracies.